Skip to content

Clinical trials

Bronchiolitis Obliterans Syndrome trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Country / region: United States Clear all

293 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20036
20046
20055
200611
200710
200812
20098
201018
201115
201210
201314
201414
201519
201614
201711
201812
201910
202013
202111
20228
202312
202419
202518
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed165
Recruiting42
Terminated39
Active, not recruiting22
Unknown status11
Withdrawn9
Suspended2
Enrolling by invitation2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dana-Farber Cancer Institute11
Fred Hutchinson Cancer Center11
National Cancer Institute (NCI)10
Incyte Corporation9
Gilead Sciences7
M.D. Anderson Cancer Center7
Novartis Pharmaceuticals6
Pfizer6
Pharmacyclics LLC.5
University of Miami5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome293
Graft vs Host Disease31
Leukemia21
Pain20
Low Back Pain13
Leukemia, Lymphocytic, Chronic, B-Cell12
Bronchiolitis Obliterans10
Hematologic Neoplasms10
Lymphoma, Follicular10
Stroke10

Trials

Showing 1 to 25 of 293. Each trial links to its page on Pharma Observatory.

193 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.